7 completed, 1 recruiting. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 7, Recruiting 1 |
Follow Intracerebral Haemorrhage: new trials by email Literature Review of Intracerebral Haemorrhage trials Research Report on Intracerebral Haemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage Standard treatment+mirabegron, Standard treatment - Intracerebral Haemorrhage | Phase 2 | Recruiting | Tianjin Medical University General Hospital | 25 | 2024-01-17 | 2026-10-20 |
| BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage IL-1Ra Kineret®, IL-1Ra Placebo - Intracerebral Haemorrhage | Phase 2 | Completed | Adrian Parry-Jones | 25 | 2019-05-17 | 2021-10-05 |
| STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units Tranexamic Acid, Normal saline - Intracerebral Haemorrhage | Phase 2 | Completed | Neuroscience Trials Australia | 201 | 2018-03-19 | 2023-09-28 |
| STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial Tranexamic Acid, Placebo - Intracerebral Haemorrhage, Stroke | Phase 2 | Completed | Neuroscience Trials Australia | 100 | 2012-12-01 | 2020-02-26 |
| Factor VIIa in Acute Intracerebral Haemorrhage eptacog alfa (activated) - Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Completed | Novo Nordisk A/S | 90 | 2006-01-01 | 2016-11-18 |
| Recombinant Factor VIIa in Acute Intracerebral Haemorrhage activated recombinant human factor VII - Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Completed | Novo Nordisk A/S | 400 | 2002-08-01 | 2017-01-18 |
| Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage activated recombinant human factor VII, placebo - Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Completed | Novo Nordisk A/S | 40 | 2001-11-01 | 2017-01-13 |
| Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage activated recombinant human factor VII, placebo - Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Completed | Novo Nordisk A/S | 48 | 2001-08-01 | 2017-01-12 |
Cerebral Hemorrhage (8) · Stroke (3) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Hemorrhage (1)
Intracranial Hemorrhages (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Hemorrhage (7) · Brain Diseases (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Nervous System Diseases (6) · Vascular Diseases (6)
Tranexamic Acid (2) · Factor VII (1) · Interleukin 1 Receptor Antagonist Protein (1) · Saline Solution (1) · Sodium Chloride (1)
Novo Nordisk A/S (4) · Neuroscience Trials Australia (2) · Adrian Parry-Jones (1) · Tianjin Medical University General Hospital (1)
Australia (4) · Finland (4) · United Kingdom (3) · Denmark (2) · Germany (2) · Italy (2) · Singapore (2) · Spain (2) · Taiwan (2) · Austria (1) · Belgium (1) · Canada (1) · China (1) · Japan (1) · Netherlands (1)
Adrian Parry-Jones, PhD, MRCP (1) · Atte Meretoja, MD (1) · Geoffrey A Donnan, MD (1) · Geoffrey Donnan, MD (1) · Henry Zhao, MD (1) · Stephen Davis, MD (1) · Stephen M Davis, MD (1)
PMID 37870112, PMID 15569871, PMID 15728810, PMID 16552014, PMID 16636233, PMID 16757825, PMID 17038942, PMID 17290026, PMID 17630481, PMID 18239180, PMID 18580208, PMID 23981692, PMID 33128912, PMID 35300248, PMID 37452707, PMID 38648814